Financials
Financial year 2025
BUVAMED from Genk, company number BE0716921654, closed financial year 2025 with a result of € 388,531 after tax. For that financial year BUVAMED recorded a gross margin of € 631,079 and equity of € 897,642. Compared with financial year 2024, the result moved from € 409,250 to € 388,531. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 897,642
▲ 41% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 388,531
▼ 5% vs 2024
Profit after tax over the fiscal year.
€ 386,033
▲ 56% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 128,261 paid out
33 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 103,160
▼ 24% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 536,005
▲ € 413,527 vs 2024
€ 48,289 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 3,255
▲ 159% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 21,203
▼ 37% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 488,050 | € 557,631 | € 612,273 | € 631,079 | ▲ 3% |
| Profit after taxes | € 336,206 | € 373,213 | € 409,250 | € 388,531 | ▼ 5% |
| Equity | € 125,835 | € 373,364 | € 637,372 | € 897,642 | ▲ 41% |
| Total debts | € 166,023 | € 143,291 | € 162,871 | € 560,463 | ▲ 244% |
| Cash | € 145,194 | € 275,223 | € 247,987 | € 386,033 | ▲ 56% |
| Land & buildings | - | € 46,017 | € 43,640 | € 487,410 | ▲ € 443,771 |
| Retained profit | € 125,635 | € 373,164 | € 637,172 | € 897,442 | ▲ 41% |
| Dividend | € 885,241 | € 125,684 | € 145,241 | € 128,261 | ▼ 12% |
| Bank debt | € 40,952 | € 86,968 | € 122,478 | € 536,005 | ▲ € 413,527 |
| Balance sheet total | € 291,858 | € 516,655 | € 800,243 | € 1,458,105 | ▲ 82% |
By gross margin, BUVAMED ranks 10th of 92 companies with main activity “Activiteiten van medisch specialisten” in Genk that publish figures (fiscal year 2025).
Key figures of BUVAMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about BUVAMED the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to BUVAMED?
What happened at BUVAMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 388,531 (▼ 5% vs 2024). filed late Source: NBB ↗
- Capital increase of € 100, published in the Gazette. Source: Staatsblad ↗
- Hanne Buyse became a director. NBB
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Genk. KBO
- Ben Van Bylen became a director. NBB
In short
From € 336,206 profit in 2022 to € 388,531 profit in 2025.
Paid € 606,904 in corporate taxes since 2022.
Best year ever: 2024, with € 409,250 profit.
Paid out € 1.3 million in dividends to the owners in total.
Management
Behind BUVAMED are Ben Van Bylen and Hanne Buyse. Hanne Buyse is also behind EPIONE IMMO.
Directors
According to the 2025 annual accounts
Ben Van Bylen
Director
since 2018
since 2021
Establishments
Establishment units
Physical locations of this company
Matenstraat 12
3600 Genk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Genk
Same main activity (Activiteiten van medisch specialisten), 107 active companies in Genk, largest first.
Medische Beeldvorming Ziekenhuis Oost-Limburg
€ 21 million revenue · 2025
BELGO-INTERNATIONAL RESEARCH APPLICATIONS en DEVELOPMENT
€ 2.4 million gross margin · 2025
€ 1.2 million gross margin · 2025
€ 897,337 gross margin · 2025
€ 859,250 gross margin · 2025
€ 818,343 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- BUYSE Hanne Julie Fran(inschrijver nieuwe aandelen) 49.5%
- VAN BYLEN Ben(inschrijver nieuwe aandelen) 0.5%
Incorporation
Source: Deed ↗- VAN BYLEN Ben(oprichter) 100%
Details
- Company number
- 0716.921.654
- VAT number
- BE 0716.921.654
- Registered office
- Matenstraat 12, 3600 Genk
- Names & denominations
- BUVAMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 December 2018
- Peppol
- Active · Active since 14 Nov 2025
- Activities · NACE
Activiteiten van medisch specialisten